Ann: FY21 Results Presentation, page-6

Lots of stuff to like in the FY report already - still only halfway through it! Also like the new product device + finalised product dev + future tests and partnerships being explored with 'multinationals'.

Even Covid19 test related sale futures are changing in Australia, which just 2mths ago seemed totally unlikely to even rate as a 'market' (+ minor whinge - we are STILL waiting for some sort of India market entry/launch despite supposedly being 'approved'!?)

Good upward rev trajectory, lower margins on average but lots more production capacity VS upward sales trend VS future capacity/pipeline dev being worked in paralle. USA market focus & biz dev is good alongside China partnership also being sought for future growth drivers (next decade). Good mid-term prospects on HIV, OEM existing & future dev pipeline

Several items to dissect n reflect over the weekend before Monday's call.